Cost-effectiveness of newer pharmacologic treatments in adults with type 2 diabetes: a systematic review of cost-effectiveness studies for the American College of Physicians
Most people do not experience severe side effects from a single expired dose
Misaligned expectations In other instances, the issue isnt how well the medication is working, but how the results are being interpreted
GLPs (glucagon-like peptide-1 receptor agonists) are medications that mimic the natural hormone, glucagon
The study aims to evaluate the effects of CT-868 on glucose homeostasis in participants with Type 1 Diabetes Mellitus (T1DM) with overweight or obesity, which is a reasonably specific patient population that could potentially benefit from a new therapeutic option
reported in pg/ml rather than pmol/l, as the exact molarity of the peptide picked up by this assay is unknown), was in sharp contrast to the results obtained using the sandwich ELISA (EZGLP1T-36K) for GLP-1 measurement (Fig